BLB: fund-raising plan approved by CSRC; Q3 net profit slumps

On 7 Nov., Baolingbao Biology Co., Ltd. (BLB)'s A-shares non-public issuance plan was approved by the China Securities Regulatory Commission (CSRC). BLB's shares will be subscribed by Beijing Yongyu Investment Management Co., Ltd., Ganzhou Zhongke Yo...

Sweeteners China News 202211

www.cnchemicals.com